Literature DB >> 7841240

Psychoactive medications and injurious motor vehicle collisions involving older drivers.

S G Leveille1, D M Buchner, T D Koepsell, L W McCloskey, M E Wolf, E H Wagner.   

Abstract

Older drivers have the second highest risk for motor vehicle collisions of any age group, after adolescents. Psychoactive medications may place older drivers at increased risk for injurious motor vehicle collisions. We conducted a population-based matched case-control study of older drivers who were involved in injurious crashes during 1987 and 1988. The 234 cases and 447 controls were members of a large Seattle-based health maintenance organization. Use of anti-depressants and opioid analgesics by older drivers was associated with increased risk for injurious motor vehicle collisions. Compared with non-users, current users of cyclic antidepressants had an adjusted relative risk (RR) of 2.3 [95% confidence interval (CI) = 1.1-4.8]. Opioid analgesic use was also associated with an elevated crash risk (adjusted RR = 1.8; 95% CI = 1.0-3.4). We found no evidence of a dose-related effect with either class of drug. Current use of benzodiazepines or sedating antihistamines had little association with increased risk for injurious collisions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7841240     DOI: 10.1097/00001648-199411000-00006

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  32 in total

1.  Insomnia symptoms and risk for unintentional fatal injuries--the HUNT Study.

Authors:  Lars Erik Laugsand; Linn B Strand; Lars J Vatten; Imre Janszky; Johan Håkon Bjørngaard
Journal:  Sleep       Date:  2014-11-01       Impact factor: 5.849

Review 2.  The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies.

Authors:  Ludivine Orriols; Louis-Rachid Salmi; Pierre Philip; Nicholas Moore; Bernard Delorme; Anne Castot; Emmanuel Lagarde
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-08       Impact factor: 2.890

3.  Prescription of antidepressants and the risk of road traffic crash in the elderly: a case-crossover study.

Authors:  Ludivine Orriols; Machelle Wilchesky; Emmanuel Lagarde; Samy Suissa
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

4.  Road traffic accidents and psychotropic medication use in The Netherlands: a case-control study.

Authors:  Silvia Ravera; Nienke van Rein; Johan J de Gier; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

Review 5.  The Role of Opioid Analgesics in Geriatric Pain Management.

Authors:  Jennifer Greene Naples; Walid F Gellad; Joseph T Hanlon
Journal:  Clin Geriatr Med       Date:  2016-08-09       Impact factor: 3.076

6.  Depression, antidepressants, and accidents.

Authors:  J G Edwards
Journal:  BMJ       Date:  1995-10-07

Review 7.  Residual effects of hypnotics: epidemiology and clinical implications.

Authors:  Annemiek Vermeeren
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

8.  Prescription medicines and the risk of road traffic crashes: a French registry-based study.

Authors:  Ludivine Orriols; Bernard Delorme; Blandine Gadegbeku; Aurore Tricotel; Benjamin Contrand; Bernard Laumon; Louis-Rachid Salmi; Emmanuel Lagarde
Journal:  PLoS Med       Date:  2010-11-16       Impact factor: 11.069

9.  Effects of three therapeutic doses of codeine/paracetamol on driving performance, a psychomotor vigilance test, and subjective feelings.

Authors:  Jean-Noël Amato; Sullivan Marie; Véronique Lelong-Boulouard; Magalie Paillet-Loilier; Catherine Berthelon; Antoine Coquerel; Pierre Denise; Marie-Laure Bocca
Journal:  Psychopharmacology (Berl)       Date:  2013-03-09       Impact factor: 4.530

10.  Testing for benzodiazepine inebriation--relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers.

Authors:  Jørgen G Bramness; Svetlana Skurtveit; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2003-09-20       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.